Ricerca

RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.

cerca in

Risultati 11 - 20 di 272 (tempo di esecuzione: 0.204 secondi).

esporta metadati
- RIS
- EndNote
- BibTeX
- Excel
- CSV
- RefWorks

A multicentre dose titration study to assess the safety tolleration and efficacy of eletriptan given for long-term treatment of migraine (with or without aura)

1996-01-01 Benedetto C

A multicentre double-blind double–dummy, parallel group study of oral Sumatriptan (100 mg) given in single dose for up to 50 attacks of migraine (with or without aura).

1996-01-01 Benedetto C

A multicentre double-blind randomized, parallel group, placebo controlled study to assess the safety and efficacy of two oral dose levels of eletriptan given for the acute treatment of migraine ( with or without aura).

1996-01-01 Benedetto C

A multicentre, double-blind randomised, placebo-controlled study to evaluate the efficacy and toleration of DHE.2.0 mg nasal spray for the treatment of migraine.

1997-01-01 Benedetto C

A phase II, randomised, double-blind, placebo controlled, multicentre study to evaluate the efficacy, safety and toleration of Sildenafil administrered for 12 weeks to women with sexual disfunction associated with female sexual disorders.Pfizer; durata: agosto 1997-aprile 1998

1997-01-01 Benedetto C

A randomised, multicentre, double-blind, desogestrel-controlled, parallel group, multiple administration, phase III study on safety of the oral monophasic contraceptive GRT 4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 desogestrel given for 6 medication cycles.

2005-01-01 Benedetto C.

A randomized, prospective, cross-over, double blind, placebo-controlled, multicentre study to assess the efficacy and tolerability of almotriptan 12.5 in the mild pain phase of menstrual migraine (MM) followed by an open follow-up evaluation to assess consistency.

2005-01-01 Benedetto C.

An open-label, group-comparative, multicentre trial to evaluate the vaginal bleeding characteristic of Nuvaring versus an oral contraceptive in healthy female.

2001-01-01 Benedetto C

An open-label, multi-center trial to assess the efficacy and safety of 24 days administration of oral a combined monophasic contraceptive with Gestodene 60 μg and Ethynilestradiol 15 μgWyeth S.p.A.

1995-01-01 Benedetto C

An open-label, multicentre study of the EVRA transdermal Patch in Europe (EVRA NRGEEP-CON-402): evaluation of women’s experience with EVRA and comparison with previously used methods of contraception.

2004-01-01 Benedetto C.

Titolo	Data di pubblicazione	Autore(i)
A multicentre dose titration study to assess the safety tolleration and efficacy of eletriptan given for long-term treatment of migraine (with or without aura)	1996	Benedetto C
A multicentre double-blind double–dummy, parallel group study of oral Sumatriptan (100 mg) given in single dose for up to 50 attacks of migraine (with or without aura).	1996	Benedetto C
A multicentre double-blind randomized, parallel group, placebo controlled study to assess the safety and efficacy of two oral dose levels of eletriptan given for the acute treatment of migraine ( with or without aura).	1996	Benedetto C
A multicentre, double-blind randomised, placebo-controlled study to evaluate the efficacy and toleration of DHE.2.0 mg nasal spray for the treatment of migraine.	1997	Benedetto C
A phase II, randomised, double-blind, placebo controlled, multicentre study to evaluate the efficacy, safety and toleration of Sildenafil administrered for 12 weeks to women with sexual disfunction associated with female sexual disorders.Pfizer; durata: agosto 1997-aprile 1998	1997	Benedetto C
A randomised, multicentre, double-blind, desogestrel-controlled, parallel group, multiple administration, phase III study on safety of the oral monophasic contraceptive GRT 4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 desogestrel given for 6 medication cycles.	2005	Benedetto C.
A randomized, prospective, cross-over, double blind, placebo-controlled, multicentre study to assess the efficacy and tolerability of almotriptan 12.5 in the mild pain phase of menstrual migraine (MM) followed by an open follow-up evaluation to assess consistency.	2005	Benedetto C.
An open-label, group-comparative, multicentre trial to evaluate the vaginal bleeding characteristic of Nuvaring versus an oral contraceptive in healthy female.	2001	Benedetto C
An open-label, multi-center trial to assess the efficacy and safety of 24 days administration of oral a combined monophasic contraceptive with Gestodene 60 μg and Ethynilestradiol 15 μgWyeth S.p.A.	1995	Benedetto C
An open-label, multicentre study of the EVRA transdermal Patch in Europe (EVRA NRGEEP-CON-402): evaluation of women’s experience with EVRA and comparison with previously used methods of contraception.	2004	Benedetto C.

Risultati 11 - 20 di 272 (tempo di esecuzione: 0.204 secondi).

↑ Back to top

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Aggiungere filtri:

Aggiungi

Opzioni

Risultati/pagina

Ordina per

In ordine

Scopri

Accesso al fulltext

no fulltext 202
reserved 68
open 2

CINECA IRIS Institutional Research Information System

A multicentre dose titration study to assess the safety tolleration and efficacy of eletriptan given for long-term treatment of migraine (with or without aura)

A multicentre double-blind double–dummy, parallel group study of oral Sumatriptan (100 mg) given in single dose for up to 50 attacks of migraine (with or without aura).

A multicentre double-blind randomized, parallel group, placebo controlled study to assess the safety and efficacy of two oral dose levels of eletriptan given for the acute treatment of migraine ( with or without aura).

A multicentre, double-blind randomised, placebo-controlled study to evaluate the efficacy and toleration of DHE.2.0 mg nasal spray for the treatment of migraine.

A phase II, randomised, double-blind, placebo controlled, multicentre study to evaluate the efficacy, safety and toleration of Sildenafil administrered for 12 weeks to women with sexual disfunction associated with female sexual disorders.Pfizer; durata: agosto 1997-aprile 1998

A randomized, prospective, cross-over, double blind, placebo-controlled, multicentre study to assess the efficacy and tolerability of almotriptan 12.5 in the mild pain phase of menstrual migraine (MM) followed by an open follow-up evaluation to assess consistency.

An open-label, group-comparative, multicentre trial to evaluate the vaginal bleeding characteristic of Nuvaring versus an oral contraceptive in healthy female.

An open-label, multi-center trial to assess the efficacy and safety of 24 days administration of oral a combined monophasic contraceptive with Gestodene 60 μg and Ethynilestradiol 15 μgWyeth S.p.A.

An open-label, multicentre study of the EVRA transdermal Patch in Europe (EVRA NRGEEP-CON-402): evaluation of women’s experience with EVRA and comparison with previously used methods of contraception.

Legenda icone

Aggiungere filtri:

Opzioni

Scopri

Tipologia

Autore

Data di pubblicazione

Rivista

Keyword

Lingua

Accesso al fulltext